Tissue damage and oxidant/antioxidant balance;Doku hasarı ve oksidan/antioksidan denge

Eurasian Journal of Medicine

Volumn 45, Issue 1, 2013, Pages 47-49

  Kisaoglu, Abdullah ^a   Borekci, Bunyamin ^a   Yapca, O Erkan ^b   Bilen, Habib ^a   Suleyman, Halis ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

^b Sorgun Devlet Hastanesi   (Turkey)

Author keywords

Antioxidant; Ischemia; Oxidant

Indexed keywords

EID: 84874282336     PISSN: 13088734     EISSN: 13088742     Source Type: Journal    
DOI: 10.5152/eajm.2013.08     Document Type: Review

References (40)

1. Clarkson PM, Thompson HS. Antioxidants: What role do they play in physical activity and health? Am J Clin Nutr 2000; 72: 637-46.
2. Yeum KJ, Russell RM, Krinsky NI, Adlini G. Biomarkers of antioxidan capacity in hydrophilic and lipophilic compartments of human plasma. Arch Biochem Biophys 2004; 430: 97-103. [CrossRef]
3. Aguilar A, Alvarez-Vijande R, Capdevila S, Alcoberro J, Alcaraz A. Antioxidant Patterns (Superoxide Dismutase, Glutathione Reductase, and Glutathione Peroxidase) in Kidneys From Non- Heart-Beating- Donors. Transplantation Proceedings 2007; 39: 249-52. [CrossRef]
4. Iraz M, Ozerol E, Gulec M, et al. Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin induced oxidative damage to liver in rat. Cell Biochem Funct 2006; 24: 357-61. [CrossRef]
5. Uzar E, Acar A, Firat U, et al. Protective effect of caffeic acid phenethyl ester in rat cerebral i{dotless}schemia/reperfusion damage. Turk Norol Derg 2011; 17: 131-6.
6. Bayir H, Kagan VE, Borisenko GG, et al. Enhanced oxidative stress in iNOS-deficient mice after traumatic brain injury: support for a neuroprotective role of iNOS. J Cereb Blood Flow Metab 2005; 25: 673-84. [CrossRef]
7. Chong ZZ, Li F, Maiese K. Oxidative stress in the brain: Novel cellular targets that governsurvival during neurodegenerative disease. Prog Neurobiol 2005; 75: 207-46. [CrossRef]
8. Shao CX, Roberts KN, Markesbery WR, Scheff SW, Lovell MA. Oxidative stress in head trauma in aging. Free Radic Biol Med 2006; 41: 77-85.
9. Eşmekaya MA, Sirav B, Ozer C, Seyhan N. Effects of radiofrequency radiation on brain tissue oxidant and antioxidant levels in rats. Gazi Med J 2011; 22: 100-4. [CrossRef]
10. Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med 2000; 109: 315-23. [CrossRef]
11. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000; 47: 446-56. [CrossRef]
12. Kelly RF. Current strategies in lung preservation. J Lab Clin Med 2000; 136, 427-40. [CrossRef]
13. Zhao G, Al-Mehdi AB, Fisher AB. Anoxia-reoxygenation versus ischemia in isolated rat lungs. Am J Physiol 1997; 273: 1112-7.
14. Al-Mehdi AB, Shuman H, Fisher AB. Intracellular generation of reactive oxygen species during nonhypoxic lung ischemia. Am J Physiol 1997; 272: 294-300.
15. Fisher AB, Dodia C, Tan ZT, Ayene I, Eckenhoff RG. Oxygendependent lipid peroxidation during lung ischemia. J Clin Invest 1991; 88: 674-9. [CrossRef]
16. Eckenhoff RG, Dodia C, Tan Z, Fisher AB. Oxygen-dependent reperfusion injury in the isolated rat lung. J Appl Physiol 1992; 72: 1454-60.
17. Harton JW, Walker PB. Oxygen radicals, lipid peroxidation and permeability changes after intestinal ischemia and reperfusion. J Appl 1993; 74: 1515-20.
18. Bilbao G, Contrenas JL. Reduction of ischemia reperfusion injury of the liver by vivo adenovirus mediated gene transfer of the antiapoptotic Bcl-2 gene. Ann Surg 1999; 230: 185-93. [CrossRef]
19. Weight SC, Bell PR, Nicholson ML. Renal ischemia reperfusion injury. Br J Surg 1996; 83: 162-70. [CrossRef]
20. Collard CD, Gehran S. Phatophysiology, clinical manifestations and prevention of ischemia reperfusion injury. Anest 2001; 94: 1122-38.
21. Carden DL, Granger DN. Phatophysiology of ischemia reperfusion injury. J Pathol 2000; 190: 255-66. [CrossRef]
22. Chamoun F, Burne M, O'Donnell M, Rabb H. Phatophysiologic role of selectins and their ligands in ischemia reperfusion injury. Front Bioscl 2000; 5: 103-9. [CrossRef]
23. Tok A, Sener E, Albayrak A, et al. Effect of mirtazapine on oxidative stress created in rat kidneys by ischemia-reperfusion. Ren Fai 2012; 34: 103-10. [CrossRef]
24. Yigiter M, Yildiz A, Polat B, et al. The protective effects of metyrosine, lacidipine, clonidine, and moxonidine on kidney damage induced by unilateral ureteral obstruction in rats. Surg Today 2012; 42: 1051-60. [CrossRef]
25. Ingec M, Isaoglu U, Yilmaz M, et al. Prevention of ischemiareperfusion injury in rat ovarian tissue with the on-off method. J Physiol Pharmacol 2011; 62: 575-82.
26. Kurt A, Isaoglu U, Yilmaz M, et al. Biochemical and histological investigation of famotidine effect on postischemic reperfusion injury in the rat ovary. J Pediatr Surg 2011; 46: 1817-23. [CrossRef]
27. Isaoglu U, Yilmaz M, Calik M, et al. Biochemical and histopathological investigation of the protective effect of disulfiram in ischemia- induced ovary damage. Gynecol Endocrinol 2012; 28: 143-7. [CrossRef]
28. Salman S, Kumbasar S, Yilmaz M, et al. Investigation of the effects of the chronic administration of some antihypertensive drugs on enzymatic and non-enzymatic oxidant/antioxidant parameters in rat ovarian tissue. Gynecol Endocrinol 2011; 27: 895-9. [CrossRef]
29. Derin N, Izgut-Uysal VN, Agac A, Aliciguzel Y, Demir N. L-carnitine protects gastric mucosa by decreasing ischemia-reperfusion induced lipid peroxidation. J Physiol Pharmacol 2004; 55: 595-606.
30. Akgun S, Tekeli A, Kurtkaya O, et al. Neuroprotective effects of FK-506, L-carnitine and azathioprine on spinal cord ischemiareperfusion injury. Eur J Cardiothorac Surg 2004; 25: 105-10. [CrossRef]
31. Kocer I, Kulacoglu D, Altuntas I, Gundogdu C, Gullulu G. Protection of the retina from ischemia-reperfusion injury by L-carnitine in guinea pigs. Eur J Ophthalmol 2003; 13: 80-5.
32. Onal A, Astarcioglu H, Ormen M, Atila K, Sarioglu S. The beneficial effect of L-carnitine in rat renal ischemia-reperfusion injury. Ulus Travma Derg 2004; 10: 160-7.
33. Atila K, Coker A, Sagol O, et al. Protective effects of carnitine in an experimental ischemia-reperfusion injury. Clin Nutr 2002; 21: 309-13. [CrossRef]
34. Calvani M, Arrigoni-Martelli E. Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion. Int J Tissue React 1999; 21: 1-6.
35. Kourounakis PN, Tsiakitzis K, Kourounakis AP, Galanakis D. Reduction of gastrointestinal toxicity of NSAIDs via molecular modifications leading to antioxidant anti-inflammatory drugs. Toxicology 2000; 144: 205-10. [CrossRef]
36. Wallace JL. Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage-potential for development of gastrointestinal tract safe NSAIDs. Can J Physiol Pharmacol 1994; 72: 1493-8. [CrossRef]
37. Niki E, Yamamoto Y, Komuro E, Sato K. Membrane damage due to lipid oxidation. Am J Clin Nutr 1991; 53: 201-5.
38. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitinproteasome pathway. N Engl J Med 1996; 335: 1897-905. [CrossRef]
39. Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol 2001; 426: 1-10. [CrossRef]
40. Sorg O. Oxidative stres: a theoretical model or biological reality? C R Biologies 2004; 327: 649-62. [CrossRef]